Related Experiment Videos

PI3K/Akt pathway mutations in retinoblastoma

Yoram Cohen1, Efrat Merhavi-Shoham, Bat Chen R Avraham-Lubin

  • 1Department of Gynecology, Sheba Medical Center, Tel Hashomer, Israel.

Investigative Ophthalmology & Visual Science
|May 8, 2009
PubMed
Abstract

Insights

The AKT1 E17K mutation was not found in retinoblastoma tumors. While the PI3K-AKT pathway is dysregulated, other mechanisms likely drive retinoblastoma development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The PI3K-AKT pathway is frequently activated in various cancers.
  • Somatic mutations in AKT1, such as E17K, can lead to abnormal pathway activation.
  • Understanding pathway involvement in retinoblastoma is crucial for targeted therapies.

Purpose of the Study:

  • To investigate the presence of AKT1 mutations in retinoblastoma.
  • To explore the role of the PI3K-AKT pathway in retinoblastoma pathogenesis.
  • To analyze mutations in related genes like PTEN, K-RAS, and PIK3CA.

Main Methods:

  • Genomic DNA analysis of 24 retinoblastoma samples.
  • Detection of AKT1, PTEN, and K-RAS mutations using MALDI-TOF mass spectrometry.
  • Direct sequencing of the PIK3CA gene in 16 samples.

Main Results:

  • No AKT1 E17K mutations were detected in the analyzed retinoblastoma samples.
  • K-RAS mutations were found in two samples; no other mutations were identified by mass array.
  • A gain-of-function mutation in PIK3CA exon 9 was observed in one sample; a polymorphism in exon 20 was found in another.

Conclusions:

  • The AKT1 E17K mutation is not a common driver in retinoblastoma.
  • Low frequencies of mutations in AKT1, PIK3CA, and PTEN suggest alternative mechanisms for PI3K-AKT pathway dysregulation in retinoblastoma.
  • Further research is needed to elucidate the precise activating mechanisms in this malignancy.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...